Cargando…
A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727122/ http://dx.doi.org/10.1186/1753-6561-3-S5-S28 |
| _version_ | 1782170656917422080 |
|---|---|
| author | Stearns, V Jacobs, L Khouri, N Jeter, S Powers, P Shahverdi, K Brown, R Rudek, M Gabrielson, E Zhang, Z Tsangaris, T Sukumar, S |
| author_facet | Stearns, V Jacobs, L Khouri, N Jeter, S Powers, P Shahverdi, K Brown, R Rudek, M Gabrielson, E Zhang, Z Tsangaris, T Sukumar, S |
| author_sort | Stearns, V |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2727122 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27271222009-08-14 A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy Stearns, V Jacobs, L Khouri, N Jeter, S Powers, P Shahverdi, K Brown, R Rudek, M Gabrielson, E Zhang, Z Tsangaris, T Sukumar, S BMC Proc Meeting Abstract BioMed Central 2009-07-24 /pmc/articles/PMC2727122/ http://dx.doi.org/10.1186/1753-6561-3-S5-S28 Text en Copyright © 2009 Stearns et al; licensee BioMed Central Ltd. |
| spellingShingle | Meeting Abstract Stearns, V Jacobs, L Khouri, N Jeter, S Powers, P Shahverdi, K Brown, R Rudek, M Gabrielson, E Zhang, Z Tsangaris, T Sukumar, S A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy |
| title | A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy |
| title_full | A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy |
| title_fullStr | A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy |
| title_full_unstemmed | A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy |
| title_short | A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy |
| title_sort | phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (pld) in women awaiting mastectomy |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727122/ http://dx.doi.org/10.1186/1753-6561-3-S5-S28 |
| work_keys_str_mv | AT stearnsv aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT jacobsl aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT khourin aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT jeters aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT powersp aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT shahverdik aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT brownr aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT rudekm aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT gabrielsone aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT zhangz aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT tsangarist aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT sukumars aphase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT stearnsv phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT jacobsl phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT khourin phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT jeters phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT powersp phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT shahverdik phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT brownr phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT rudekm phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT gabrielsone phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT zhangz phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT tsangarist phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy AT sukumars phase1studyassessingthefeasibilityandsafetyofintraductalpegylatedliposomaldoxorubicinpldinwomenawaitingmastectomy |